The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence

Journal of Virology

Volumn 81, Issue 15, 2007, Pages 8293-8302

  Lemon, Ken ^a   Rima, Bertus K ^a   McQuaid, Stephen ^b   Allen, Ingrid V ^a   Duprex, W Paul ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; LIVE VACCINE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASEPTIC MENINGITIS; CELL FUSION; GENE EXPRESSION; GENETIC TRANSFECTION; HYDROCEPHALUS; LEWIS RAT; MUMPS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VACCINATION; VERO CELL; VIRAL GENETICS; VIRUS GENE; VIRUS MENINGITIS; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; BASE SEQUENCE; BRAIN; CELL LINE; HUMANS; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VACCINE; MUMPS VIRUS; RATS; RATS, INBRED LEW; VACCINES, ATTENUATED; VIRAL FUSION PROTEINS; VIRAL PROTEINS;

EUKARYOTA; MUMPS VIRUS; RATTUS; RODENTIA;

EID: 34547091944     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00266-07     Document Type: Article

References (51)

1. Afzal, M. A., S. A. Marsden, R. M. Hull, P. A. Pipkin, M. L. Bentley, and P. D. Minor. 1999. Evaluation of the neurovirulence test for mumps vaccines. Biologicals 27:43-49.
2. Afzal, M. A., A. R. Pickford, T. Forsey, A. B. Heath, and P. D. Minor. 1993. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J. Gen. Virol. 74:917-920.
3. Afzal, M. A., P. J. Yates, and P. D. Minor. 1998. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps Urabe vaccine strain. J. Infect. Dis. 177:265-266.
4. Amexis, G., N. Fineschi, and K. Chumakov. 2001. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287: 234-241.
5. Beck, M., R. Welsz-Malecek, M. Mesko-Prejac, V. Radman, M. Juzbasic, M. Rajninger-Miholic, M. Prislin-Musklic, V. Dobrovsak-Sourek, S. Smerdel, and D. W. Stainer. 1989. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J. Biol. Stand. 17:85-90.
6. Black, S., H. Shinefield, P. Ray, E. Lewis, R. Chen, J. Glasser, S. Hadler, J. Hardy, P. Rhodes, E. Swint, R. Davis, R. Thompson, J. Mullooly, M. Marcy, C. Vadheim, J. Ward, S. Rastogi, and R. Wise. 1997. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr. Infect. Dis. J. 16:500-503.
7. Boulianne, N., G. De Serres, S. Ratnam, B. J. Ward, J. R. Joly, and B. Duval. 1995. Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination. Vaccine 13: 1611-1616.
8. Brown, E. G., K. Dimock, and K. E. Wright. 1996. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J. Infect. Dis. 174:619-622.
9. Buynak, E. B., and M. R. Hilleman. 1966. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc. Soc. Exp. Biol. Med. 123:768-775.
10. Cathomen, T., C. J. Buchholz, P. Spielhofer, and R. Cattaneo. 1995. Preferential initiation at the second AUG of the measles virus F mRNA: a role for the long untranslated region. Virology 214:628-632.
11. Centers for Disease Control and Prevention (CDC). 2006. Mumps epidemic - United Kingdom, 2004-2005. Morb. Mortal. Wkly. Rep. 55:173-175.
12. Choppin, P. W. 1963. Multiplication of two kinds of influenza A2 virus particles in monkey kidney cells. Virology 21:342-352.
13. Cizman, M., M. Mozetic, R. Radescek-Rakar, D. Pleterski-Rigler, and M. Susec-Michieli. 1989. Aseptic meningitis after vaccination against measles and mumps. Pediatr. Infect. Dis. J. 8:302-308.
14. Clarke, D. K., M. S. Sidhu, J. E. Johnson, and S. A. Udem. 2000. Rescue of mumps virus from cDNA. J. Virol. 74:4831-4838.
15. Duprex, W. P., I. Duffy, S. McQuaid, L. Hamill, S. L. Cosby, M. A. Billeter, J. Schneider-Schaulies, V. ter Meulen, and B. K. Rima. 1999. The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain. J. Virol. 73:6916-6922.
16. Duprex, W. P., S. McQuaid, L. Hangartner, M. A. Billeter, and B. K. Rima. 1999. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus. J. Virol. 73:9568-9575.
17. Elango, N., T. M. Varsanyi, J. Kovamees, and E. Norrby. 1988. Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J. Gen. Virol. 69:2893-2900.
18. Enders, J. F. 1946. Techniques of laboratory diagnosis, tests for susceptibility and experiments on specific prophylaxis. J. Pediatr. 29:129-142.
19. Furesz, J., and G. Contreras. 1990. Vaccine-related mumps meningitis - Canada. Can. Dis. Wkly. Rep. 16:253-254.
20. Kancherla, V. S., and I. C. Hanson. 2006. Mumps resurgence in the United States. J. Allergy Clin. Immunol. 118:938-941.
21. Kilham, L., and J. R. Overman. 1953. Natural pathogenicity of mumps virus for suckling hamsters on intracerebral inoculation. J. Immunol. 70:147-151.
22. Kovamees, J., R. Rydbeck, C. Orvell, and E. Norrby. 1990. Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus. Virus Res. 17:119-129.
23. Kristensson, K., C. Orvell, G. Malm, and E. Norrby. 1984. Mumps virus infection of the developing mouse brain - appearance of structural virus proteins demonstrated with monoclonal antibodies. J. Neuropathol. Exp. Neurol. 43:131-140.
24. Love, A., R. Rydbeck, K. Kristensson, C. Orvell, and E. Norrby. 1985. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J. Virol. 53:67-74.
25. Mazhul', L. A., and O. N. Ageeva. 1983. Enzyme activity of the neuraminidase from various strains of the influenza A virus. Vopr. Virusol. 28:43-46. (In Russian.)
26. Merz, D. C., A. C. Server, M. N. Waxham, and J. S. Wolinsky. 1983. Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. J. Gen. Virol. 64:1457-1467.
27. Merz, D. C., and J. S. Wolinsky. 1981. Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology 114:218- 227.
28. Mori, C., T. Tooriyama, T. Imagawa, and K. Yamanishi. 1997. Nucleotide sequence at position 1081 of the hemagglutinin-neuraminidase gene in the mumps virus Urabe vaccine strain. J. Infect. Dis. 175:1548-1549.
29. Nagai, Y., H. D. Klenk, and R. Rott. 1976. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72:494-508.
30. Orvell, C. 1984. The reactions of monoclonal antibodies with structural proteins of mumps virus. J. Immunol. 132:2622-2629.
31. Paterson, R. G., and R. A. Lamb. 1990. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J. Virol. 64:4137-4145.
32. Rafiefard, F., B. Johansson, T. Tecle, and C. Orvell. 2005. Characterization of mumps virus strains with varying neurovirulence. Scand. J. Infect. Dis. 37:330-337.
33. Rubin, S. A., G. Amexis, M. Pletnikov, Z. Li, J. Vanderzanden, J. Mauldin, C. Sauder, T. Malik, K. Chumakov, and K. M. Carbone. 2003. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J. Virol. 77:11616-11624.
34. Rubin, S. A., M. Pletnikov, and K. M. Carbone. 1998. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain. J. Virol. 72:8037-8042.
35. Rubin, S. A., M. Pletnikov, R. Taffs, P. J. Snoy, D. Kobasa, E. G. Brown, K. E. Wright, and K. M. Carbone. 2000. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J. Virol. 74:5382-5384.
36. Rubin, S. A., P. J. Snoy, K. E. Wright, E. G. Brown, P. Reeve, J. A. Beeler, and K. M. Carbone. 1999. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains. J. Infect. Dis. 180: 521-525.
37. Sauder, C. J., K. M. Vandenburgh, R. C. Iskow, T. Malik, K. M. Carbone, and S. A. Rubin. 2006. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity. Virology 350:48-57.
38. Sinclair, C., M. Mirakhur, J. Kirk, M. Farrell, and S. McQuaid. 2005. Up-regulation of osteopontin and αα-crystallin in the normal-appearing white matter of multiple sclerosis: an immunohistochemical study utilizing tissue microarrays. Neuropathol. Appl. Neurobiol. 31:292-303.
39. Smorodintsev, A. A., M. N. Nasibov, and N. V. Jakovleva. 1970. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Bull. W. H. O. 42:283-289.
40. Tanabayashi, K., K. Takeuchi, K. Okazaki, M. Hishiyama, and A. Yamada. 1992. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology 187:801-804.
41. Tecle, T., B. Bottiger, C. Orvell, and B. Johansson. 2001. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J. Gen. Virol. 82:2675-2680.
42. Tecle, T., A. Mickiene, B. Johansson, L. Lindquist, and C. Orvell. 2002. Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch. Virol. 147:243-253.
43. Tesovic, G., J. Begovac, and A. Bace. 1993. Aseptic meningitis after measles, mumps, and rubella vaccine. Lancet 341:1541.
44. Vesikari, T., F. E. Andre, E. Simoen, G. Florent, E. L. Ala-Laurila, A. Heikkinen, H. Kuusinen, and A. Terho. 1983. Evaluation in young children of the Urabe Am 9 strain of live attenuated mumps vaccine in comparison with the Jeryl Lynn strain. Acta Paediatr. Scand. 72:37-40.
45. Waxham, M. N., and J. Aronowski. 1988. Identification of amino acids involved in the sialidase activity of the mumps virus hemagglutinin- neuraminadase protein. Virology 167:226-232.
46. Reference deleted.
47. WHO. 1994. WHO Expert Committee on Biological Standardization. WHO Tech. Rep. Ser. 840:1-218.
48. Wilson, R. L., S. M. Fuentes, P. Wang, E. C. Taddeo, A. Klatt, A. J. Henderson, and B. He. 2006. Function of small hydrophobic proteins of paramyxovirus. J. Virol. 80:1700-1709.
49. Wolinsky, J. S. 1996. Mumps virus, p. 1243-1265. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, Philadelphia, PA.
50. Wolinsky, J. S., T. Klassen, and J. R. Baringer. 1976. Persistence of neuro-adapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J. Infect. Dis. 133:260-267.
51. Wolinsky, J. S., and W. G. Stroop. 1978. Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch. Virol. 57:355-359.